<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827537</url>
  </required_header>
  <id_info>
    <org_study_id>2019121819</org_study_id>
    <nct_id>NCT04827537</nct_id>
  </id_info>
  <brief_title>Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone</brief_title>
  <official_title>Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      20-hydroxyecdysone is an ecdysteroid hormone found in invertebrates and plants.&#xD;
      20-hydroxyecdysone exhibits a broad range of biological properties in various in vitro and in&#xD;
      vivo models, including anabolic, antioxidant, anti-inflammatory, immunomodulatory,&#xD;
      anti-obesity and antidiabetic activities, in addition to acting as neuroprotective and&#xD;
      hepatoprotective agent. Ecdysteroids are widely used by athletes as dietary supplements to&#xD;
      increase strength and muscle mass during resistance training, to reduce fatigue and to ease&#xD;
      recovery. Mhashilkar AS et al. (2016) were revealed anti-parasitic activity of&#xD;
      20-hydroxyecdysone against the human filarial parasites. According to recent searches in&#xD;
      academic databases and medical search engines (Google, www.google.com; PubMed,&#xD;
      www.ncbi.nlm.nih.gov/pubmed; and Medline, www.medline.com), no studies have been conducted to&#xD;
      assess the anti-protozoal activity of 20-hydroxyecdysone.&#xD;
&#xD;
      The aim of the study is to assess anti-protozoal activity of 20-hydroxyecdysone in water&#xD;
      sports athletes with giardiasis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The randomized, double-blinded, placebo-controlled clinical study will be conducted by the&#xD;
      Uzbek State University of Physical Education and Sport, Institute of the Chemistry of Plant&#xD;
      Substances named acad. S. Yu. Yunusov and Republican Specialized Scientific and Practical&#xD;
      Medical Center of Epidemiology, Microbiology, Infectious and Parasitic Diseases, Tashkent,&#xD;
      Uzbekistan&#xD;
&#xD;
      Both informed and written consents will be obtained from the participants.&#xD;
&#xD;
      Study participants will be included about 200 athletes aged 18 to 27 years with giardiasis.&#xD;
      All the participants will be residents of Uzbekistan.&#xD;
&#xD;
      Diagnosis of giardiasis will be based on the results of parasitological examination.&#xD;
      Inclusion criteria:presence of giardia intestinalis in the stool samples of participant.&#xD;
&#xD;
      The exclusion criteria: chronic and acute infectious diseases, endocrine diseases, congenital&#xD;
      diseases, allergic dermatitis, bronchial asthma, allergic rhinitis and/or conjunctivitis,&#xD;
      other skin disorders, history of using vitamin D supplements within three months ago, or use&#xD;
      of any medication influencing endocrine parameters.&#xD;
&#xD;
      Measurement of anthropometric indices Demographic data will be obtained in the survey&#xD;
      included age, gender, and body mass index (BMI) calculated as weight (kg)/height2 (m2).&#xD;
&#xD;
      Blood Sample Collection and Storage Five milliliters of peripheral venous blood sample will&#xD;
      be taken (after 8-12 hours of fasting) from each participant and will be collected into&#xD;
      HumaTube Serum Gel - C/A for ELISA. Serum will be appropriately obtained and stored at -20Â°C&#xD;
      maximum of 30 days. All blood samples will be collected before and after therapy.&#xD;
&#xD;
      200 water sports athletes with Giardia infection will be randomized from 1 to 3 groups to&#xD;
      receive 20-hydroxyecdysone, metronidazole and placebo preparations, respectively&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anti-protozoal effect of steroid hormone 20-hydroxyecdysone</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Detection of Anti-protozoal effect of steroid hormone 20-hydroxyecdysone</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Giardia Lamblia Infection</condition>
  <arm_group>
    <arm_group_label>20-hydroxyecdysone group</arm_group_label>
    <description>water sports athletes with Giardia infection will receive 20-hydroxyecdysone (100 mg (one pill) x two times a day orally), 10 consecutive days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metronidazole group</arm_group_label>
    <description>water sports athletes with Giardia infection will receive metronidazole, 500 mg (one pill) x two times a day orally, 10 consecutive days&#xD;
, and placebo preparations, respectively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <description>water sports athletes with Giardia infection will receive placebo preparation, 100 mg (one pill) x two times a day orally, 10 consecutive days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>20-hydroxyecdysone Oral</intervention_name>
    <description>100 mg (one pill) x two times a day orally, 10 consecutive days</description>
    <arm_group_label>20-hydroxyecdysone group</arm_group_label>
    <other_name>ecdysterone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole Oral</intervention_name>
    <description>500 mg (one pill) x two times a day orally, 10 consecutive days</description>
    <arm_group_label>metronidazole group</arm_group_label>
    <other_name>Metronidazole</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral</intervention_name>
    <description>100 mg (one pill) x two times a day orally, 10 consecutive days</description>
    <arm_group_label>placebo group</arm_group_label>
    <other_name>shugar pills</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        male water sport athletes infected with giardia lamblia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - a presence of giardia lamblia in stool samples of partisipants&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic and acute infectious diseases,&#xD;
&#xD;
          -  endocrine diseases, congenital diseases,&#xD;
&#xD;
          -  allergic dermatitis,&#xD;
&#xD;
          -  bronchial asthma,&#xD;
&#xD;
          -  allergic rhinitis and/or conjunctivitis,&#xD;
&#xD;
          -  other skin disorders,&#xD;
&#xD;
          -  history of using vitamin D supplements within three months ago, or use of any&#xD;
             medication influencing endocrine parameters.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>27 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdurakhim Toychiev, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>research institute of epidemiology, microbiology and infectious diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research institute of epidemiology, microbiology and infectious diseases</name>
      <address>
        <city>Tashkent</city>
        <state>Uchtepa</state>
        <zip>100133</zip>
        <country>Uzbekistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uzbekistan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan</investigator_affiliation>
    <investigator_full_name>Svetlana Osipova, MD, PhD, DS</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Giardiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

